US and India-based Genetic diagnostics firm MedGenome Wednesday said it has raised $55 million in a fresh funding round led by global impact investment firm LeapFrog Investments.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
